Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) EBITDA Margin (2016 - 2025)

Cross Country Healthcare's EBITDA Margin history spans 16 years, with the latest figure at 35.04% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 3382.0% year-over-year to 35.04%; the TTM value through Dec 2025 reached 9.01%, down 792.0%, while the annual FY2025 figure was 9.01%, 792.0% down from the prior year.
  • EBITDA Margin reached 35.04% in Q4 2025 per CCRN's latest filing, down from 1.94% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 12.11% in Q4 2021 to a low of 35.04% in Q4 2025.
  • Average EBITDA Margin over 5 years is 1.18%, with a median of 3.18% recorded in 2021.
  • Peak YoY movement for EBITDA Margin: soared 979bps in 2021, then plummeted -3382bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 12.11% in 2021, then tumbled by -52bps to 5.78% in 2022, then crashed by -62bps to 2.19% in 2023, then tumbled by -156bps to 1.23% in 2024, then plummeted by -2760bps to 35.04% in 2025.
  • Per Business Quant, the three most recent readings for CCRN's EBITDA Margin are 35.04% (Q4 2025), 1.94% (Q3 2025), and 2.43% (Q2 2025).